Proscia Upgrades Flagship Software to Enable Rapid Modernization of Diagnostic Pathology In Post-Pandemic Era
Next generation of Concentriq accelerates enterprise adoption of AI-enabled digital pathology.
PHILADELPHIA–(BUSINESS WIRE)–Proscia®, a leading provider of digital and computational pathology solutions, has introduced the next generation of its flagship Concentriq® platform to help the world’s largest laboratory networks keep pace with the growing need for diagnostic services in the post-COVID era. The latest version, which will be unveiled during the virtual “Future Ready Pathology” event on June 15th, delivers performance, functionality, and design enhancements that drive meaningful quality and efficiency gains in routine pathology diagnosis for multi-site and remote operations.
Demand for digital pathology has surged as adapting to the pandemic and post-pandemic era has intensified systemic challenges long threatening the traditional laboratory model. The shift to remote work has disrupted the current standard of care centered around pathologists and microscopes in physical spaces, exacerbating mounting pressures created by a shrinking pathologist population, rising biopsy volume, and industry consolidation. Laboratories are now rapidly seeking to modernize their pathology operations to further their commitment to excellent patient care; however, legacy software systems that do not scale across the enterprise or fit into the pathologist’s day-to-day workflow have prevented them from achieving this transformation.
Proscia’s Concentriq platform is used by top reference laboratories and health systems to shift the standard of care from microscope to image. The new release enables even the largest networked laboratories to rapidly adopt digital pathology by delivering the performance, security, and connectivity needed to scale across distributed operations.
Concentriq now offers new and improved capabilities to:
- Put the pathologist at the center of a powerful new experience as intuitive as the microscope. The latest version of Concentriq is designed to drive meaningful productivity and efficiency gains by delivering a natural, microscope-like viewing experience from within a robust digital pathology environment. Pathologists can now enhance their familiar workflow with streamlined sharing, improved access to expertise, and the ability to work remotely.
- Unify multi-site laboratory networks in a single, future-proof platform. Geographically-dispersed pathologists can carry out their day-to-day work from within a shared platform as if they were all practicing from one location. A single deployment of Concentriq now supports an unlimited number of sites and users, as well as multiple laboratory information systems (LIS) and scanner types, to meet their current and future needs.
- Accelerate case review and expand the breadth of diagnostic information with optional AI applications. The next generation of Concentriq empowers laboratories to embrace pathology’s computational future with confidence. The platform’s open API enables users to seamlessly incorporate AI applications, including solutions developed by Proscia and other third parties, into routine operations and view results alongside all other pathology data.
“Digital and computational pathology is the only way we will continue to serve our patients in these unprecedented times, yet critical gaps in the underlying technology have prevented us from fully capitalizing on our implementation,” said Dr. Alexi Baidoshvili, Clinical Pathologist at LabPON, the first laboratory in the world to reach 100% digital pathology diagnosis. “Concentriq meets the needs of both our individual pathologists and large networked laboratory environment. With Concentriq, we can finally scale our adoption to drive quality and productivity gains while realizing the promise of AI.”
Proscia’s Concentriq is the platform of choice for leading organizations, including LabPON, the Joint Pathology Center, and University Medical Center Utrecht. It can be deployed on existing IT infrastructure and works with any scanner and laboratory information system, offering seamless integrations with Philips, Leica, 3DHISTECH, and Hamamatsu among other solutions.
“Pathology is under more pressure than ever before,” said David West, CEO of Proscia. “We’ve enhanced Concentriq to provide laboratories with the robust capabilities needed to accelerate adoption, helping them to better operate in the new normal and improve patient outcomes. In doing so, we’re also advancing pathology’s computational future by empowering laboratories to tap into data-driven approaches.”
To learn more about the next generation of Concentriq, register for “Future Ready Pathology” on June 15th at 11AM ET. The event will feature informative sessions, panel discussions, and insights from digital health and laboratory pioneers, including former FDA commissioner Dr. Scott Gottlieb, to help pathologists, laboratory management, and information technology teams prepare for rapid modernization.
About Proscia
Proscia is a software company that is changing the way the world practices pathology to transform research and diagnosis for diseases like cancer. With the company’s Concentriq digital pathology platform and pipeline of AI-powered applications, laboratories are leveraging new kinds of data to accelerate discoveries and improve patient outcomes. Proscia’s team of technologists, scientists, and pathologists is bringing a fresh approach to an outdated industry, helping the world to keep pace with the increasing demand for pathology services and fulfill the promise of precision diagnostics. For more information, visit proscia.com.
Source: Proscia
